Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage

Background: Primary membranous nephropathy (PMN) is an autoimmune glomerular disease. IL-6 is a potential therapeutic target for PMN. Previous clinical studies have demonstrated the effectiveness of Mahuang Fuzi and Shenzhuo Decoction (MFSD) in treating membranous nephropathy. However, the mechanism...

Full description

Bibliographic Details
Main Authors: Qihan Zhao, Haoran Dai, Hanxue Jiang, Naiqian Zhang, Fanyu Hou, Yang Zheng, Yu Gao, Wenbin Liu, Zhendong Feng, Yuehong Hu, Xinyue Tang, Hongliang Rui, Baoli Liu
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332224004670